1. Gawędzki J, Hryniewiecki L. Żywienie człowieka. Podstawy nauki o żywieniu. Wyd.

2. PWN. Warszawa 2000. 2. Erdman JW, Macdonald IA., Zeisel SH. Present knowledge in nutrition. Wyd. 10. Wiley-Blackwell. Waszyngton 2012.

3. Andrews NC, Forging a field: the golden age of iron biology. Blood 2008; 112: 219-230.

4. Ponka P. Cell biology of heme. Am. J. Med. Sci. 1999; 318:241–256.

5. Hentze MW. Muckenthaler MU, Galy B i wsp. Two to tango: regulation of mammalian iron metabolism. Cell 2010; 142:24-38.

6. Ścibior D, Czeczot H. Katalaza – budowa, właściwości, funkcje. Postępy Hig. Med., Dosw. (online) 2006; 60:170-180.

7. Milczarek R, Ruda J, Kaletha K i wsp. Udział reaktywnych form tlenu w utlenianiu i redukcji żelaza w mikrosomach łożyska ludzkiego i nowy potencjalny mechanizm działania dysmutazy ponadtlenkowej i peroksydazy glutationowej. Ann. Acad. Med. Gedan. 2009; 39: 103-113.

8. Buczko P, Cylwik D, Stokowska W.Metabolizm tryptofanu w ślinie szlakiem kinureninowym. Postepy Hig. Med. Dosw. (online) 2005; 59:283-289.

9. Ruf J, Carayon P. Structural and functional aspects of thyroid peroxidase. Arch. Biochem. Biophys. 2006; 445:269-277.

10. Picot D, Loll PJ, Garavito RM. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature 1994; 367(6460):243-249.

11. Goldblatt MI, Choi SH. Swartz-Basile DAJ i wsp. Iron deficiency suppresses ileal nitric oxide synthase activity. Gastrointest. Surg. 2001; 5(4):393-399.

12. Poulos TL. Soluble guanylate cyclase. Curr. Opin. Chem. Biol. 2006; 16:736–743.

13. Middelhaufe S, Leipelt M, Levin LR i wsp. Identification of a haem domain in human soluble adenylate cyclase. Biosci. Rep. 2012; 32(5):491-499.

14. Hurrell R. Egli I. Iron bioavailability and dietary reference values. Am. J. Clin. Nutr. 2010; 91:1461S-1467S.

15. Carpenter CE, Mahoney AW. Contributions of heme and nonheme iron to human nutrition. Crit. Rev. Food Sci. Nutr. 1992; 31:333-367.

16. Anderson GJ, Frazer DM, Mckie AT i wsp. Mechanisms of haem and non-haem iron absorption: lessons from inherited disorders of iron metabolism. Biometals 2005; 18:339-348.

17. Mckie AT, Barrow D, Latunde-Dada GO i wsp. An iron regulated ferric reductase associated with the absorption of dietary iron. Science 2001; 291:1755–1759.

18. Andrews NC. The iron transporter DMT1. Int. J. Biochem. Cell Biol. 1999; 31(10):991-994.

19. Anderson GJ, Frazer DM, McKie AT i wsp. The ceruloplasmin homolog hephaestin and the control of intestinal iron absorption. Blood Cells Mol. Dis. 2002; 29(3):367-375.

20. Weaver J, Pollack S. Iron binding to apotransferrin. Acta Haematol. 1990; 84(2):68-71.

21. Pakdaman R, Abdallah FB, Hage Chahine JM. Transferrin, is a mixed chelate-protein ternary complex involved in the mechanism of iron uptake by serum-transferrin in vitro? J. Mol. Biol. 1999; 293(5):1273-1284.

22. Le Blanc S, Garrick MD, Arredondo M. Heme carrier protein 1 transports heme and is involved in heme-Fe metabolism. Am. J. Physiol. Cell Physiol. 2012; 302(12):C1780-C1785.

23. Kikuchi G, Yoshida T, Noguchi M. Heme oxygenase and heme degradation. Biochem. Biophys. Res. Commun. 2005; 338(1):558-567.

24. Barisani D, Conte D. Transferrin receptor 1 (TfR1) and putative stimulator of Fe transport (SFT) expression in iron deficiency and overload: an overview. Blood Cells Mol. Dis. 2002; 29(3):498-505.

25. Arosio P, Levi S. Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim. Biophys. Acta 2010; 800(8):783-792.

26. Valenti L, Canavesi E, Galmozzi E i wsp. Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology 2010; 53 (5):927-933.

27. Kruszewski M. Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat. Res. 2003; 531:81-92.

28. Ganz T. Iron homeostasis: fitting the puzzle pieces together. Cell. Metabolism 2008; 7:288-290.

29. Zaritsky J. Young B. Wang H i wsp. Hepcidin-a potential novel biomarker for iron status in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2009; 4:1051-1056.

30. Caquet R. 250 badań laboratoryjnych. Wyd 1. PZWL. Warszawa 2009.

31. Sułek K. Diagnostyka i leczenie niedokrwistości. W: Dmoszyńska A, Robak T. red. Podstawy hematologii. Wydawnictwo Czelej. Lublin 2003; s. 185-189.

32. Orlicz-Szczęsna G, Żelazowska-Posiej J, Kucharska K. Niedokrwistość z niedoboru żelaza. Curr. Probl. Psychiatry 2011; 12(4):590-594.

33. Lee PL, Beutler E. Regulation of hepcidin and iron-overload disease. Annu. Rev. Pathol. Mech. Dis. 2009; 4:489-515.

34. Pietrangelo A. Hereditary hemochromatosis: pathogeneis, diagnosis, and treatment. Gastroenterology 2010; 139:393-408.

35. Shander A. Sazama K. Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy. Transfusion 2010; 50:1144-1155.

36. Cook JD, Bayens RD, Skikne BS. Iron deficiency and the measurement of iron status. Nutr. Res. Rev. 1992; 5:189-202.

37. Jarosz M. Normy żywienia dla populacji polskiej – nowelizacja.

38. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academy Press. Washington 2001.

39. Wawer I. Suplementy dla Ciebie. WEKTOR. Warszawa 2009.

40. Andreini C, Banci L, Bertini I i wsp. Counting the zinc-proteins encoded In the human genome. J. Proteome Res. 2006; 5:196-201.

41. Berg JM, Tymoczko JL, Stryer L. Biochemia. PWN. Warszawa 2005.

42. Gapys B, Raszeja-Specht A, Bielarczyk H. Role of zinc in physiological and pathological processes of the body. J. Lab. Diagn. 2014; 50(1):45-52.

43. El Hendy HA, Yousef MI, El-Naga NIA. Effect of dietary zinc deficiency on hematological and biochemical parameters and concentrations of zinc, copper, and iron in growing rats. Toxicology 2001; 167:163-170.

44. Nikonorow M, Urbanek- Karłowska B. Toksykologia żywności. PZWL. Warszawa 1987.

45. Gawęcki J, Grzymisławski M. Żywienie człowieka zdrowego i chorego. Tom II. PWN. Warszawa 2012.

46. Clohessy PA, Golden BE. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defense. Scand. J. Immunol. 1995; 42:551-556.

47. Donangelo CM, King JC. Maternal zinc intakes and homeostatic adjustments during pregnancy and lactation. Nutrients 2012; 4:782-798.

48. Seńczuk W. Toksykologia. PZWL. Warszawa 1999.

49. Bonaventura P, Lavocat F, Benedetti G. Zinc and cadmium homeostasis is altered in rheumatoid arthritis synoviocytes. Ann. Rheum. Dis. 2014; 74:A8.

50. Liuzzi JP, Cousins RJ. Mammalian zinc transporters. Annu. Rev. Nutr. 2004; 24:151-172.

51. Garrick MD, Dolan KG, Horbinski C i wsp. DMT1: a mammalian transporter for multiple metals. Biometals 2003; 16(1):41-54.

52. Institute of Medicine, Food and Nutrition Board, Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academy Press. Washington 2001.

53. Plum LM, Lothar R, Hajo H. The Essential Toxin: Impact of Zinc on Human Health. Int. J. Environ. Res. Public Health 2010; 7:1342-1365.

54. Puzanowska-Tarasiewicz H, Kuźmicka ., Tarasiewicz M. Funkcje biologiczne wybranych pierwiastków. III. Cynk-składnik i aktywator enzymów. Pol. Merk. Lek. 2009; 161:419-422.

55. Ogiso T, Moriyama K, Sasaki S i wsp. Inhibitory effect of high dietary zinc on copper absorption in rats. Chem. Pharm. Bull. 1974; 22:55-60.

56. Sandstead HH. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am. J. Clin. Nutr. 1995; 61:621S-624S.

57. Solomons NW, Jacob RA. Studies on the bioavailability of zinc in humans: effects of heme and nonheme iron on the absorption of zinc. Am. J. Clin. Nutr. 1981; 34: 475–482.

58. Solomons N.W, Pineda O, Viteri F. i wsp. Studies on the bioavailability of zinc in humans: mechanism of the intestinal interaction of nonheme iron and zinc. J. Nutr 1983; 113: 337-349.

59. Valberg LS, Flanagan PR, Chamberlain MJ. Effects of iron, tin, and copper onzinc absorption in humans. Am. J. Clin. Nutr.1984; 40:536-541.

60. Sandstroem B, Abrahamson H. Zinc absorption and achlorhydria. Eur. J. Clin. Nutr. 1989; 43: 877-879.

61. Campbell-Brown M, Ward R.J, Haines AP i wsp. Zinc and copper in Asian pregnacies – is there evidence for a nutritional deficiency? Br. J. Obstet. Gynaecol. 1985; 92:875–885.

62. Breskin MW, Worthington-Roberts BS, Knopp RH i wsp. First trimester serum zinc concentration in human pregnancy. Am. J. Clin. Nutr. 1983; 38:943-953. Instytut Żywności i Żywienia. Warszawa 2012.